Bridgefront Capital’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-17,189
Closed -$65K 311
2021
Q2
$65K Buy
+17,189
New +$65K 0.02% 572